Kura Oncology, Inc.
Kura Oncology, Inc. scores highest on Nitro (61) and lowest on Price (4). Its PosiPenta is 35.23 out of 100, weaker than most similar companies.
On the Penta Grid this week, Kura Oncology, Inc. is Grid #664 of 837 in the Healthcare sector in United States, and Grid #3,284 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Kura Oncology, Inc. | 35.23 | 4 | 32 | 61 | 25 | 54 |
| Alumis Inc. | 31.51 | 31 | 29 | 26 | 42 | 30 |
| P3 Health Partners Inc. | 31.02 | 6 | 41 | 34 | 17 | 57 |
| Obsidian Therapeutics, Inc. | 24.91 | 0 | 26 | 16 | 51 | 32 |
| Corvus Pharmaceuticals, Inc. | 40.68 | 18 | 34 | 37 | 69 | 45 |
| Verastem, Inc. | 38.26 | 4 | 42 | 83 | 9 | 53 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -2.69 |
| P/B ratio | 16.68 |
EEarnings
| Trailing EPS | ₹-319.19 |
| Forward EPS | ₹-222.49 |
NNitro
| Price | 860.01 |
| 52-week high | 1316.54 |
| 52-week low | 696.91 |
| Fall from 52-week high | 34.7% |
TTorque
| Return on equity (ROE) | -167.71% |
| Debt-to-equity | 0.51 |
AAnchor
| Beta (price swings) | 0.47 |
| Market cap | ₹7,650 Cr |
| Insider holding | 1.40% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Kura Oncology, Inc.'s PosiPenta score?
Kura Oncology, Inc.'s PosiPenta is 35.23 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Kura Oncology, Inc. stand on the Penta Grid?
On the Penta Grid this week, Kura Oncology, Inc. is Grid #664 of 837 in the Healthcare sector in United States, and Grid #3,284 of 4,000 in United States.
Which PosiPenta pillar is strongest for Kura Oncology, Inc.?
Nitro (momentum), with a score of 61 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Kura Oncology, Inc.?
Price (valuation), with a score of 4 out of 100: much weaker than most similar companies.
Has Kura Oncology, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.96 points, from 33.27 to 35.23.
PositoAI is for research and education only and is not investment advice.